Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Dual Inhibition of TAF1 and BET Bromodomains from the BI-2536 Kinase Inhibitor Scaffold.

Remillard D, Buckley DL, Seo HS, Ferguson FM, Dhe-Paganon S, Bradner JE, Gray NS.

ACS Med Chem Lett. 2019 Sep 13;10(10):1443-1449. doi: 10.1021/acsmedchemlett.9b00243. eCollection 2019 Oct 10.

PMID:
31620231
2.

A Smartphone App for Improving Mental Health through Connecting with Urban Nature.

McEwan K, Richardson M, Sheffield D, Ferguson FJ, Brindley P.

Int J Environ Res Public Health. 2019 Sep 12;16(18). pii: E3373. doi: 10.3390/ijerph16183373.

3.

Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14.

Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS.

Bioorg Med Chem Lett. 2019 Aug 1;29(15):1985-1993. doi: 10.1016/j.bmcl.2019.05.024. Epub 2019 May 23.

PMID:
31175010
4.

Discovery of Covalent CDK14 Inhibitors with Pan-TAIRE Family Specificity.

Ferguson FM, Doctor ZM, Ficarro SB, Browne CM, Marto JA, Johnson JL, Yaron TM, Cantley LC, Kim ND, Sim T, Berberich MJ, Kalocsay M, Sorger PK, Gray NS.

Cell Chem Biol. 2019 Jun 20;26(6):804-817.e12. doi: 10.1016/j.chembiol.2019.02.015. Epub 2019 Mar 28.

PMID:
30930164
5.

Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models.

Silva MC, Ferguson FM, Cai Q, Donovan KA, Nandi G, Patnaik D, Zhang T, Huang HT, Lucente DE, Dickerson BC, Mitchison TJ, Fischer ES, Gray NS, Haggarty SJ.

Elife. 2019 Mar 25;8. pii: e45457. doi: 10.7554/eLife.45457.

6.

Shmapped: development of an app to record and promote the well-being benefits of noticing urban nature.

McEwan K, Richardson M, Brindley P, Sheffield D, Tait C, Johnson S, Sutch H, Ferguson FJ.

Transl Behav Med. 2019 Mar 5. pii: ibz027. doi: 10.1093/tbm/ibz027. [Epub ahead of print]

PMID:
30834438
7.

Addressing the conundrums of p-phenylenediamine hair dye allergy by applying Friedmann's principles of contact sensitization.

Ferguson FJ, Pongpairoj K, Basketter DA, White IR, McFadden JP.

Contact Dermatitis. 2019 Apr;80(4):234-237. doi: 10.1111/cod.13171. Epub 2018 Dec 19.

PMID:
30411370
8.

Structural and Atropisomeric Factors Governing the Selectivity of Pyrimido-benzodiazipinones as Inhibitors of Kinases and Bromodomains.

Wang J, Erazo T, Ferguson FM, Buckley DL, Gomez N, Muñoz-Guardiola P, Diéguez-Martínez N, Deng X, Hao M, Massefski W, Fedorov O, Offei-Addo NK, Park PM, Dai L, DiBona A, Becht K, Kim ND, McKeown MR, Roberts JM, Zhang J, Sim T, Alessi DR, Bradner JE, Lizcano JM, Blacklow SC, Qi J, Xu X, Gray NS.

ACS Chem Biol. 2018 Sep 21;13(9):2438-2448. doi: 10.1021/acschembio.7b00638. Epub 2018 Aug 31.

9.

What's new in psoriasis treatment? An analysis of systematic reviews published in 2015.

Foulkes AC, Ferguson F, Grindlay DJC, Williams HC, Griffiths CEM, Warren RB.

Clin Exp Dermatol. 2018 Oct;43(7):759-765. doi: 10.1111/ced.13601. Epub 2018 May 27. Review.

PMID:
29806111
10.

Kinase inhibitors: the road ahead.

Ferguson FM, Gray NS.

Nat Rev Drug Discov. 2018 May;17(5):353-377. doi: 10.1038/nrd.2018.21. Epub 2018 Mar 16. Review.

PMID:
29545548
11.

Characterization of a highly selective inhibitor of the Aurora kinases.

Ferguson FM, Doctor ZM, Chaikuad A, Sim T, Kim ND, Knapp S, Gray NS.

Bioorg Med Chem Lett. 2017 Sep 15;27(18):4405-4408. doi: 10.1016/j.bmcl.2017.08.016. Epub 2017 Aug 10.

PMID:
28818446
12.

Discovery of a Series of 5,11-Dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-ones as Selective PI3K-δ/γ Inhibitors.

Ferguson FM, Ni J, Zhang T, Tesar B, Sim T, Kim ND, Deng X, Brown JR, Zhao JJ, Gray NS.

ACS Med Chem Lett. 2016 Aug 2;7(10):908-912. eCollection 2016 Oct 13.

13.

Gas/solid carbon branching ratios in surface-mediated reactions and the incorporation of carbonaceous material into planetesimals.

Nuth JA, Johnson NM, Ferguson FT, Carayon A.

Meteorit Planet Sci. 2016 Jul;51(7):1310-1322. doi: 10.1111/maps.12666. Epub 2016 Jun 7.

14.
15.

Molecular basis of histone tail recognition by human TIP5 PHD finger and bromodomain of the chromatin remodeling complex NoRC.

Tallant C, Valentini E, Fedorov O, Overvoorde L, Ferguson FM, Filippakopoulos P, Svergun DI, Knapp S, Ciulli A.

Structure. 2015 Jan 6;23(1):80-92. doi: 10.1016/j.str.2014.10.017. Epub 2014 Dec 18.

16.

Chemical biology. A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes.

Baud MGJ, Lin-Shiao E, Cardote T, Tallant C, Pschibul A, Chan KH, Zengerle M, Garcia JR, Kwan TT, Ferguson FM, Ciulli A.

Science. 2014 Oct 31;346(6209):638-641. doi: 10.1126/science.1249830. Epub 2014 Oct 16.

17.

Binding hotspots of BAZ2B bromodomain: Histone interaction revealed by solution NMR driven docking.

Ferguson FM, Dias DM, Rodrigues JP, Wienk H, Boelens R, Bonvin AM, Abell C, Ciulli A.

Biochemistry. 2014 Oct 28;53(42):6706-16. doi: 10.1021/bi500909d. Epub 2014 Oct 15.

18.

Physiotherapists' understanding of red flags for back pain.

Ferguson FC, Morison S, Ryan CG.

Musculoskeletal Care. 2015 Mar;13(1):42-50. doi: 10.1002/msc.1079. Epub 2014 Jun 26.

PMID:
24965065
19.

Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.

Ferguson FM, Fedorov O, Chaikuad A, Philpott M, Muniz JR, Felletar I, von Delft F, Heightman T, Knapp S, Abell C, Ciulli A.

J Med Chem. 2013 Dec 27;56(24):10183-7. doi: 10.1021/jm401582c. Epub 2013 Dec 13.

20.

Time and cost analysis: pediatric dental rehabilitation with general anesthesia in the office and the hospital settings.

Rashewsky S, Parameswaran A, Sloane C, Ferguson F, Epstein R.

Anesth Prog. 2012 Winter;59(4):147-53. doi: 10.2344/0003-3006-59.4.147.

21.

Case report: Noonan-like multiple central giant cell granuloma syndrome.

Bitton N, Alexander S, Ruggiero S, Parameswaran A, Russo A, Ferguson F.

Pediatr Dent. 2012 Sep-Oct;34(5):144-7.

PMID:
23211900
22.

Psychogenic nonepileptic seizures in US veterans.

Salinsky M, Spencer D, Boudreau E, Ferguson F.

Neurology. 2011 Sep 6;77(10):945-50. doi: 10.1212/WNL.0b013e31822cfc46.

PMID:
21893668
23.
24.

Oral health status and access-to-care concerns of Suffolk County Head Start children.

Goldberg E, Lewis P, Ferguson F.

N Y State Dent J. 2011 Jan;77(1):20-2.

PMID:
21417161
25.

Low back pain and physiotherapy use of red flags: the evidence from Scotland.

Ferguson F, Holdsworth L, Rafferty D.

Physiotherapy. 2010 Dec;96(4):282-8. doi: 10.1016/j.physio.2010.01.001. Epub 2010 Mar 30.

PMID:
21056162
26.

A national framework for supporting improvements in the physiotherapy assessment and management of low back pain: the Scottish experience.

Ferguson F, Holdsworth L, Rafferty D.

Physiotherapy. 2010 Sep;96(3):198-205. doi: 10.1016/j.physio.2010.02.001. Epub 2010 Mar 30.

PMID:
20674651
27.

The influence of buoyant convection on the nucleation of n-propanol in thermal diffusion cloud chambers.

Ferguson FT, Heist RH, Nuth JA.

J Chem Phys. 2010 May 28;132(20):204510. doi: 10.1063/1.3429618.

PMID:
20515103
28.

Long-term management of a child with regional odontodysplasia: a case report.

Ferguson F, Schlissel E, Kucine A, Alexander S, DeSantis A, Hendricks R, Xu L.

Pediatr Dent. 2009 Jul-Aug;31(4):346-9.

PMID:
19722446
29.

Home oral health practice: the foundation for desensitization and dental care for special needs.

Ferguson FS, Cinotti D.

Dent Clin North Am. 2009 Apr;53(2):375-87, xi. doi: 10.1016/j.cden.2008.12.009.

PMID:
19269405
30.

A Delphi study investigating consensus among expert physiotherapists in relation to the management of low back pain.

Ferguson FC, Brownlee M, Webster V.

Musculoskeletal Care. 2008 Dec;6(4):197-210. doi: 10.1002/msc.126.

PMID:
18311847
31.

Interactive Web technology provides significant advantages in oral health education.

Ferguson F.

School Nurse News. 2006 Nov;23(5):22-4. No abstract available.

PMID:
17176733
32.

The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning.

Wikby A, Nilsson BO, Forsey R, Thompson J, Strindhall J, Löfgren S, Ernerudh J, Pawelec G, Ferguson F, Johansson B.

Mech Ageing Dev. 2006 Aug;127(8):695-704. Epub 2006 Jun 5.

PMID:
16750842
33.

Viral coinfection in the oral cavity of HIV-infected children: relation among HIV viral load, CD4+ T lymphocyte count and detection of EBV, CMV and HSV.

Grando LJ, Machado DC, Spitzer S, Nachman S, Ferguson F, Berentsen B, Yurgel LS.

Braz Oral Res. 2005 Jul-Sep;19(3):228-34. Epub 2005 Nov 21.

34.

Experimental studies of the vapor phase nucleation of refractory compounds. VI. The condensation of sodium.

Martínez DM, Ferguson FT, Heist RH, Nuth JA 3rd.

J Chem Phys. 2005 Aug 1;123(5):054323.

PMID:
16108655
35.

An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans.

Wikby A, Ferguson F, Forsey R, Thompson J, Strindhall J, Löfgren S, Nilsson BO, Ernerudh J, Pawelec G, Johansson B.

J Gerontol A Biol Sci Med Sci. 2005 May;60(5):556-65.

PMID:
15972602
36.

Use of mental health and substance abuse treatment services by female injection drug users.

Amodeo M, Chassler D, Ferguson F, Fitzgerald T, Lundgren L.

Am J Drug Alcohol Abuse. 2004;30(1):101-20.

PMID:
15083556
37.

[The association between oral manifestations and the socioeconomic and cultural characteristics of HIV-infected children in Brazil and in the United States of America].

Grando LJ, Yurgel LS, Machado DC, Nachman S, Ferguson F, Berentsen B, Fernandes A.

Rev Panam Salud Publica. 2003 Aug;14(2):112-8. Spanish.

PMID:
14577934
38.

Examining drug treatment program entry of injection drug users: human capital and institutional disaffiliation.

Lundgren LM, Schilling RF, Ferguson F, Davis K, Amodeo M.

Eval Program Plann. 2003 May;26(2):123-32. doi: 10.1016/S0149-7189(03)00013-2.

PMID:
24011480
39.

Morbidity does not influence the T-cell immune risk phenotype in the elderly: findings in the Swedish NONA Immune Study using sample selection protocols.

Nilsson BO, Ernerudh J, Johansson B, Evrin PE, Löfgren S, Ferguson FG, Wikby A.

Mech Ageing Dev. 2003 Apr;124(4):469-76.

PMID:
12714255
40.

Basic oral health concerns.

Ferguson F.

School Nurse News. 2002 Sep;19(4):40-2; quiz 43. No abstract available.

PMID:
12365129
41.
42.

Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study.

Wikby A, Johansson B, Olsson J, Löfgren S, Nilsson BO, Ferguson F.

Exp Gerontol. 2002 Jan-Mar;37(2-3):445-53.

PMID:
11772532
43.

Envy rising.

Ferguson F.

ELH. 2002;69(4):889-905. No abstract available.

PMID:
21043215
44.

Racial and ethnic differences in drug treatment entry of injection drug users in Massachusetts.

Lundgren LM, Amodeo M, Ferguson F, Davis K.

J Subst Abuse Treat. 2001 Oct;21(3):145-53.

PMID:
11728788
45.

The SENIEUR protocol after 16 years.

Pawelec G, Ferguson FG, Wikby A.

Mech Ageing Dev. 2001 Feb;122(2):132-4. No abstract available.

PMID:
11166351
46.

Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study.

Olsson J, Wikby A, Johansson B, Löfgren S, Nilsson BO, Ferguson FG.

Mech Ageing Dev. 2000 Dec 20;121(1-3):187-201.

PMID:
11164473
47.

Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study.

Wikby A, Maxson P, Olsson J, Johansson B, Ferguson FG.

Mech Ageing Dev. 1998 May 15;102(2-3):187-98.

PMID:
9720651
48.
49.

Preweaning variables' influence on market traits in rabbits.

Ferguson FA, Lukefahr SD, McNitt JI.

J Anim Sci. 1997 Mar;75(3):611-21.

PMID:
9078475
50.

Implications and management of oral diseases in children and adolescents with HIV infection.

Ferguson FS, Nachman S, Berentsen B.

N Y State Dent J. 1997 Feb;63(2):46-50.

PMID:
9090257

Supplemental Content

Loading ...
Support Center